DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Sullivan HC, Gerner-Smidt C, Nooka AK, Arthur CM, Thompson L, Mener A. et al.
Daratumumab (anti-CD38) induces loss of CD38 on red blood cells.
Blood 2017;
129: 3033-7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.